The British stock market in 2024 has been on a winning streak, with the FTSE 100 index up by almost 11% since mid-January. This surge in performance, which jumps to 13% when including dividends, has caught the attention of investors who have been patiently waiting for a rally.
But what is driving these double-digit gains? The answer lies in the correction that the stock market experienced in recent years. While corrections can be challenging for investors, they also create opportunities to invest in top-notch businesses at bargain prices. This has led to a resurgence in the market, with the FTSE 100 trading near an all-time high.
Key players in this rally include companies like AstraZeneca, Shell, HSBC Holdings, and Unilever, whose share prices have seen significant growth since the start of the year. AstraZeneca, in particular, has been propelled by the success of its cancer drugs, with revenue from this division soaring by 26%.
Looking ahead, AstraZeneca has ambitious plans to increase its total revenue stream to $80 billion by 2030, presenting a significant growth opportunity for investors. However, there are risks involved, as drug development is a complex and unpredictable process.
Investors are advised to stay disciplined and maintain a diversified portfolio to balance the potential opportunities with the risks involved in the market. The 2024 stock market rally may be a once-in-a-decade chance for investors to capitalize on bargains, but caution is key in navigating the volatile market landscape.
The post 2024 stock market rally: a final chance for once-in-a-decade bargains? appeared first on The Motley Fool UK.
